Medexus Pharmaceuticals Inc.
MEDXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $61,024 | $75,485 | $45,899 | $59,715 |
| - Cash | $9,381 | $9,332 | $23,973 | $8,441 |
| + Debt | $21,067 | $21,895 | $37,178 | $39,913 |
| Enterprise Value | $72,710 | $88,048 | $59,104 | $91,187 |
| Revenue | $24,741 | $24,615 | $24,754 | $29,992 |
| % Growth | 0.5% | -0.6% | -17.5% | – |
| Gross Profit | $13,786 | $13,774 | $12,432 | $15,191 |
| % Margin | 55.7% | 56% | 50.2% | 50.7% |
| EBITDA | $3,508 | $4,447 | $3,682 | $4,632 |
| % Margin | 14.2% | 18.1% | 14.9% | 15.4% |
| Net Income | -$315 | $516 | -$553 | $733 |
| % Margin | -1.3% | 2.1% | -2.2% | 2.4% |
| EPS Diluted | -0.01 | 0.016 | -0.02 | 0.03 |
| % Growth | -159.3% | 181.4% | -167% | – |
| Operating Cash Flow | $3,337 | $3,919 | $2,276 | $6,710 |
| Capital Expenditures | -$7 | -$125 | -$53 | -$104 |
| Free Cash Flow | $3,330 | $3,794 | $2,223 | $6,606 |